Home / Healthcare
Industry
Healthcare market research
Medical devices, diagnostics, therapeutics, nutrition and health software.
All healthcare markets
| Market | Value 2026 | Value 2036 | CAGR 2026-36 | Largest country |
|---|---|---|---|---|
| 1-Step RT-PCR Kits | USD 728 mn | USD 1.2 bn | 5.0% | United States |
| 3D Cell Culture | USD 2.7 bn | USD 8.4 bn | 12.0% | United States |
| 3D Imaging Surgical Solution | USD 1.5 bn | USD 3.3 bn | 8.5% | United States |
| AI Aortic Surgery Planning Tool | USD 55 mn | USD 186 mn | 13.0% | United States |
| AI Capsule Endoscopy Reading Platform | USD 64 mn | USD 306 mn | 17.0% | United States |
| AI Osteoporosis Screening Tools | USD 74 mn | USD 386 mn | 18.0% | United States |
| AI based Triage Tools | USD 802 mn | USD 3.5 bn | 16.0% | United States |
| AI enhanced Mammography Screening | USD 434 mn | USD 2.5 bn | 19.0% | United States |
| AI-Accelerated Nonclinical Drug Testing | USD 1.2 bn | USD 4.4 bn | 14.0% | United States |
| AI-Assisted Clinical Trial Protocol Design | USD 378 mn | USD 2.3 bn | 20.0% | United States |
| AI-Driven Cardiac Diagnostics | USD 1.3 bn | USD 5.9 bn | 16.0% | United States |
| AI-Powered Behavioral Therapy | USD 768 mn | USD 3.7 bn | 17.0% | United States |
| AI-Powered Gait & Mobility Analytics | USD 151 mn | USD 429 mn | 11.0% | United States |
| AI-powered Care Coordination | USD 905 mn | USD 3.4 bn | 14.0% | United States |
| AI-powered Spinal Surgery | USD 881 mn | USD 2.7 bn | 12.0% | United States |
| Abdominal Closure Systems | USD 509 mn | USD 955 mn | 6.5% | United States |
| Absorbable PGA Surgical Sutures | USD 228 mn | USD 321 mn | 3.5% | United States |
| Absorbable PGLA Surgical Sutures | USD 853 mn | USD 1.3 bn | 4.0% | United States |
| Absorbance Micro plate Reader | USD 494 mn | USD 804 mn | 5.0% | United States |
| Active Pharmaceutical Ingredient | USD 245 bn | USD 460 bn | 6.5% | United States |
| Adaptive Stroller | USD 362 mn | USD 648 mn | 6.0% | United States |
| Advanced Humidification Incubator | USD 401 mn | USD 685 mn | 5.5% | China |
| Advanced Implantable Electrode Neurotechnology | USD 1.2 bn | USD 2.6 bn | 7.8% | United States |
| Alzheimer's Blood Test | USD 299 mn | USD 2.6 bn | 24.0% | United States |
| Ambulatory Surgery Center | USD 64.2 bn | USD 129 bn | 7.2% | United States |
| Amniotic Membrane | USD 2.2 bn | USD 4.9 bn | 8.5% | United States |
| Ampoule | USD 1.0 bn | USD 1.4 bn | 3.6% | China |
| Amyotrophic Lateral Sclerosis Gene Testing | USD 62 mn | USD 167 mn | 10.5% | United States |
| Animal Immunoassay Kits | USD 1.5 bn | USD 2.9 bn | 7.0% | United States |
| Animal Wound Care | USD 1.6 bn | USD 3.2 bn | 7.0% | United States |
| Aniridia Implants | USD 14 mn | USD 29 mn | 7.5% | United States |
| Anti-Neoplastic Pharmaceutical Agents | USD 239 bn | USD 591 bn | 9.5% | United States |
| Antibody Drug Conjugates | USD 16.5 bn | USD 63.8 bn | 14.5% | United States |
| Aquaculture Fungal Infection Treatment | USD 90 mn | USD 161 mn | 6.0% | China |
| Artificial Pancreas Device | USD 6.2 bn | USD 20.0 bn | 12.5% | United States |
| Ascites Fluid Removal Devices | USD 276 mn | USD 494 mn | 6.0% | United States |
| Aseptic Filling | USD 4.8 bn | USD 10.4 bn | 8.0% | United States |
| Assistive Robots for Disability | USD 694 mn | USD 2.0 bn | 11.0% | United States |
| At-Home Syphilis Testing | USD 58 mn | USD 495 mn | 24.0% | United States |
| Augmented Glenoid Systems | USD 251 mn | USD 567 mn | 8.5% | United States |
| Autoinjector | USD 3.7 bn | USD 9.5 bn | 10.0% | United States |
| Automated CPR Device | USD 253 mn | USD 432 mn | 5.5% | United States |
| Autonomous AI Powered Ophthalmology Screening | USD 124 mn | USD 547 mn | 16.0% | United States |
| Behavioral Health Care Coordination | USD 806 mn | USD 2.3 bn | 11.0% | United States |
| Behavioral Health Continuum Solutions | USD 4.0 bn | USD 10.8 bn | 10.5% | United States |
| Bioabsorbable Stents | USD 92 mn | USD 181 mn | 7.0% | Germany |
| Biobanking | USD 3.2 bn | USD 7.3 bn | 8.5% | United States |
| Biologics | USD 508 bn | USD 1.1 tn | 8.0% | United States |
| Biomarker Discovery | USD 8.7 bn | USD 25.7 bn | 11.5% | United States |
| Biopharmaceutical Logistics | USD 21.7 bn | USD 51.4 bn | 9.0% | United States |
| Bioreactor | USD 13.7 bn | USD 35.5 bn | 10.0% | United States |
| Biosafety Cabinet | USD 958 mn | USD 1.9 bn | 7.0% | United States |
| Biosimilars | USD 37.8 bn | USD 153 bn | 15.0% | United States |
| Biospecimen Logistics | USD 3.9 bn | USD 9.3 bn | 9.0% | United States |
| Birch Allergy Treatment | USD 307 mn | USD 551 mn | 6.0% | Germany |
| Bladder Cancer Array | USD 308 mn | USD 729 mn | 9.0% | United States |
| Blister Machine | USD 1.4 bn | USD 2.4 bn | 5.5% | India |
| Blood Bag Tube Sealer | USD 58 mn | USD 90 mn | 4.5% | United States |
| Bone Densitometer Devices | USD 543 mn | USD 868 mn | 4.8% | United States |
| Bone Morphogenetic Protein | USD 316 mn | USD 516 mn | 5.0% | United States |
| Brachytherapy Treatment Planning Systems | USD 95 mn | USD 168 mn | 5.8% | United States |
| Breast Cancer Grading Tools | USD 102 mn | USD 490 mn | 17.0% | United States |
| CRISPR and Cas Gene | USD 2.9 bn | USD 10.1 bn | 13.5% | United States |
| CRISPR-Integrated Gene Editing Delivery Devices | USD 366 mn | USD 994 mn | 10.5% | United States |
| Cancer Survivorship Nutrition | USD 554 mn | USD 1.0 bn | 6.5% | United States |
| Canine Fungal Infection Treatment | USD 159 mn | USD 272 mn | 5.5% | United States |
| Capsule Endoscope and Workstations | USD 562 mn | USD 1.2 bn | 7.5% | United States |
| Capsule Filling Machine | USD 686 mn | USD 1.2 bn | 5.5% | India |
| Capsule | USD 3.4 bn | USD 6.4 bn | 6.5% | United States |
| Carboxylate-Modified Magnetic Beads | USD 201 mn | USD 433 mn | 8.0% | United States |
| Cardiovascular Devices | USD 83.8 bn | USD 165 bn | 7.0% | United States |
| Cardiovascular Drug Discovery | USD 2.6 bn | USD 5.3 bn | 7.5% | United States |
| Cardiovascular Enterprise Viewer | USD 486 mn | USD 1.0 bn | 7.5% | United States |
| Carpal Tunnel Release System | USD 127 mn | USD 217 mn | 5.5% | United States |
| Cartridge | USD 1.7 bn | USD 3.4 bn | 7.2% | United States |
| Catheter-Based Pulmonary Embolism Thrombectomy | USD 1.1 bn | USD 3.5 bn | 12.0% | United States |
| Catheter-Directed Thrombolysis | USD 452 mn | USD 931 mn | 7.5% | United States |
| Cell Culture | USD 23.9 bn | USD 51.5 bn | 8.0% | United States |
| Cell Culture Media | USD 7.4 bn | USD 15.9 bn | 8.0% | United States |
| Cell Therapy | USD 9.4 bn | USD 58.0 bn | 20.0% | United States |
| Cell-Free DNA Testing Transplant | USD 462 mn | USD 1.2 bn | 10.0% | United States |
| Centrifuge | USD 1.7 bn | USD 3.0 bn | 6.0% | United States |
| Cervical Spacer Systems | USD 746 mn | USD 1.3 bn | 6.0% | United States |
| Chromatography | USD 12.6 bn | USD 22.5 bn | 6.0% | United States |
| Chromatography Resin | USD 2.6 bn | USD 6.7 bn | 9.8% | United States |
| Cleanroom Consumable | USD 6.7 bn | USD 13.9 bn | 7.5% | United States |
| Cleanroom Equipment | USD 6.0 bn | USD 13.0 bn | 8.0% | United States |
| Clinic-Based Rehab Therapy Robots | USD 632 mn | USD 1.6 bn | 9.5% | United States |
| Clinical Nutrition | USD 35.3 bn | USD 69.5 bn | 7.0% | United States |
| Clinical Trial Supply | USD 5.7 bn | USD 13.4 bn | 9.0% | United States |
| Clinical Trials | USD 118 bn | USD 232 bn | 7.0% | United States |
| Closed-Loop Centesis Systems | USD 341 mn | USD 640 mn | 6.5% | United States |
| Colorimetric Fructosamine Assay Kit | USD 57 mn | USD 92 mn | 4.8% | China |
| Companion Diagnostics | USD 7.6 bn | USD 22.6 bn | 11.5% | United States |
| Comparator Sourcing | USD 976 mn | USD 2.2 bn | 8.5% | United States |
| Continuous Flow Bioreactors | USD 549 mn | USD 1.6 bn | 11.0% | United States |
| Continuous Peripheral Nerve Block Catheter | USD 243 mn | USD 395 mn | 5.0% | United States |
| Continuous Positive Airway Pressure (CPAP) | USD 3.1 bn | USD 5.8 bn | 6.5% | United States |
| Contract Development and Manufacturing Organization | USD 140 bn | USD 303 bn | 8.0% | United States |
| Contract Research Organization | USD 91.8 bn | USD 198 bn | 8.0% | United States |
| Cosmetic Peptide Manufacturing | USD 456 mn | USD 984 mn | 8.0% | South Korea |
| Cystic Fibrosis Nutrition Products | USD 145 mn | USD 204 mn | 3.5% | United States |
| Dengue Vaccines | USD 247 mn | USD 1.8 bn | 22.0% | Brazil |
| Dental Autoclaves | USD 355 mn | USD 552 mn | 4.5% | United States |
| Dental Care | USD 58.3 bn | USD 104 bn | 6.0% | United States |
| Dental Implantology Software | USD 283 mn | USD 641 mn | 8.5% | United States |
| Dental Oral Microbiome | USD 255 mn | USD 662 mn | 10.0% | United States |
| Dental Sterilization | USD 2.0 bn | USD 3.6 bn | 6.0% | United States |
| Dermatology Cryosurgery Units | USD 158 mn | USD 257 mn | 5.0% | United States |
| Diabetes Care | USD 32.7 bn | USD 77.4 bn | 9.0% | United States |
| Diabetes Drugs | USD 97.5 bn | USD 159 bn | 5.0% | United States |
| Diagnostic Exosome Biomarkers | USD 242 mn | USD 977 mn | 15.0% | United States |
| Dietary Supplement | USD 198 bn | USD 389 bn | 7.0% | United States |
| Digital Colony Counter | USD 59 mn | USD 101 mn | 5.5% | United States |
| Digital Health | USD 271 bn | USD 921 bn | 13.0% | United States |
| Digital Orthodontics Workflow Solutions | USD 1.8 bn | USD 4.8 bn | 10.5% | United States |
| Digital Stethoscope | USD 286 mn | USD 742 mn | 10.0% | United States |
| Digital Therapeutics | USD 7.9 bn | USD 49.1 bn | 20.0% | United States |
| Digital Twins Technologies | USD 967 mn | USD 6.5 bn | 21.0% | United States |
| Downstream Processing | USD 16.6 bn | USD 45.0 bn | 10.5% | United States |
| Drug Delivery Systems | USD 67.0 bn | USD 145 bn | 8.0% | United States |
| Drug Discovery Services | USD 26.4 bn | USD 71.7 bn | 10.5% | United States |
| Drug Store | USD 1.4 tn | USD 2.1 tn | 4.5% | United States |
| Dual Lumen ECMO Catheter | USD 73 mn | USD 166 mn | 8.5% | United States |
| Dystrophic Epidermolysis Bullosa Management | USD 632 mn | USD 1.4 bn | 8.0% | United States |
| Early Pulmonary Embolism Thrombectomy Device | USD 935 mn | USD 2.9 bn | 12.0% | United States |
| Elderly-Care & Companion Robots | USD 690 mn | USD 2.6 bn | 14.0% | Japan |
| Electronic Health Records | USD 40.9 bn | USD 80.4 bn | 7.0% | United States |
| Emergency Transfer Vacuum Mattress | USD 74 mn | USD 120 mn | 5.0% | United States |
| Endoluminal & Bronchoscopy Robots | USD 976 mn | USD 4.7 bn | 17.0% | United States |
| Endoscopic Closure Systems | USD 817 mn | USD 1.6 bn | 7.0% | United States |
| Endoscopic Imaging Logistics And Service | USD 1.0 bn | USD 1.7 bn | 5.5% | United States |
| Engine-Driven Endodontic File | USD 536 mn | USD 889 mn | 5.2% | United States |
| Enzyme Linked Immunosorbent Assay | USD 3.1 bn | USD 5.1 bn | 5.2% | United States |
| Eosinophilic Esophagitis | USD 1.4 bn | USD 4.3 bn | 12.0% | United States |
| Epilepsy Monitoring Devices | USD 942 mn | USD 1.9 bn | 7.5% | United States |
| Extended-Action Local Anaesthetic | USD 684 mn | USD 1.4 bn | 7.5% | United States |
| Extracorporeal Membrane Oxygenation Machine | USD 405 mn | USD 796 mn | 7.0% | United States |
| Extracorporeal Membrane Oxygenation | USD 738 mn | USD 1.3 bn | 5.5% | United States |
| Fat Modular Nutrition | USD 147 mn | USD 239 mn | 5.0% | United States |
| Federated Learning Drug Discovery | USD 104 mn | USD 642 mn | 20.0% | United States |
| Federated Learning Healthcare | USD 78 mn | USD 571 mn | 22.0% | United States |
| Fermentation | USD 10.3 bn | USD 23.2 bn | 8.5% | China |
| Fiber Modular Nutrition | USD 121 mn | USD 207 mn | 5.5% | United States |
| Fiber Supplements | USD 6.4 bn | USD 12.0 bn | 6.5% | United States |
| Fill Finish | USD 17.6 bn | USD 41.7 bn | 9.0% | United States |
| Filtration Membrane | USD 10.3 bn | USD 23.3 bn | 8.5% | United States |
| Flow Cytometry | USD 5.7 bn | USD 11.8 bn | 7.5% | United States |
| Fluid Bed Dryer | USD 742 mn | USD 1.3 bn | 6.0% | China |
| Frozen Clinical Meal | USD 1.3 bn | USD 1.9 bn | 3.8% | United Kingdom |
| Gene Synthesis | USD 2.8 bn | USD 11.2 bn | 15.0% | United States |
| Gene Therapy | USD 11.3 bn | USD 82.8 bn | 22.0% | United States |
| Generic Drugs | USD 462 bn | USD 753 bn | 5.0% | United States |
| Generic Injectable | USD 93.3 bn | USD 172 bn | 6.3% | United States |
| Glioblastoma Treatment Drugs | USD 945 mn | USD 1.6 bn | 5.5% | United States |
| Good Manufacturing Practice Compliance | USD 6.3 bn | USD 14.2 bn | 8.5% | United States |
| HIV Self-testing | USD 259 mn | USD 534 mn | 7.5% | United States |
| Handheld Point-of-Care Ultrasound | USD 660 mn | USD 1.6 bn | 9.5% | United States |
| Health Insurance | USD 2.5 tn | USD 4.6 tn | 6.0% | United States |
| Healthcare API | USD 1.8 bn | USD 8.0 bn | 16.0% | United States |
| Healthcare Provider Workflow Optimization | USD 3.4 bn | USD 9.3 bn | 10.5% | United States |
| Healthcare Reimbursement Optimization | USD 8.2 bn | USD 22.2 bn | 10.5% | United States |
| High-end Cellomics | USD 610 mn | USD 1.2 bn | 7.0% | United States |
| Home Healthcare | USD 410 bn | USD 886 bn | 8.0% | United States |
| Home Infusion Smart Pump Accessories | USD 445 mn | USD 836 mn | 6.5% | United States |
| Hospital Capacity Management Solutions | USD 1.0 bn | USD 2.9 bn | 11.0% | United States |
| Hospital Pharmacy | USD 509 bn | USD 937 bn | 6.3% | United States |
| Hospital Supplies | USD 200 bn | USD 342 bn | 5.5% | United States |
| Hospital-at-Home Monitoring Platforms | USD 608 mn | USD 2.5 bn | 15.0% | United States |
| Hospital-at-Home Vital Signs Monitoring Platforms | USD 614 mn | USD 2.5 bn | 15.0% | United States |
| Immunoadsorption Columns | USD 160 mn | USD 301 mn | 6.5% | Germany |
| Immunoassay | USD 43.5 bn | USD 81.6 bn | 6.5% | United States |
| Immunohistochemistry | USD 3.5 bn | USD 7.5 bn | 8.0% | United States |
| Immunotherapy | USD 77.7 bn | USD 176 bn | 8.5% | United States |
| Impedance-based TEER Measurement System | USD 120 mn | USD 284 mn | 9.0% | United States |
| Implantable Drug Delivery | USD 12.9 bn | USD 27.3 bn | 7.8% | United States |
| Implantable Tibial Neuromodulation | USD 22 mn | USD 139 mn | 20.0% | United States |
| In Vitro Diagnostics | USD 108 bn | USD 184 bn | 5.5% | United States |
| Infusion Pump | USD 6.9 bn | USD 11.5 bn | 5.2% | United States |
| Inhalation Drug Delivery | USD 40.1 bn | USD 68.5 bn | 5.5% | United States |
| Injectable Drug Delivery | USD 19.6 bn | USD 46.4 bn | 9.0% | United States |
| Insulin Delivery | USD 16.8 bn | USD 36.3 bn | 8.0% | United States |
| Intracameral Antibiotics | USD 128 mn | USD 241 mn | 6.5% | United States |
| Intraoperative Neurophysiological Monitoring Electrode | USD 277 mn | USD 520 mn | 6.5% | United States |
| Isokinetic Diagnostic and Training System | USD 110 mn | USD 188 mn | 5.5% | United States |
| Isolator | USD 1.5 bn | USD 3.2 bn | 8.2% | United States |
| Kidney Transplant Rejection Biomarker | USD 319 mn | USD 755 mn | 9.0% | United States |
| Laboratory Automation | USD 7.0 bn | USD 15.2 bn | 8.0% | United States |
| Laboratory Information Management System | USD 2.7 bn | USD 6.8 bn | 9.5% | United States |
| Lacrimal Devices | USD 87 mn | USD 141 mn | 5.0% | United States |
| Lactation Nutrition Products | USD 342 mn | USD 643 mn | 6.5% | United States |
| Laminar Air Flow | USD 689 mn | USD 1.3 bn | 6.5% | China |
| Lateral Flow Assay | USD 10.0 bn | USD 16.3 bn | 5.0% | United States |
| Liposome | USD 5.2 bn | USD 11.1 bn | 8.0% | United States |
| Liquid Handling | USD 6.0 bn | USD 12.5 bn | 7.5% | United States |
| Long Term Care | USD 1.0 tn | USD 1.7 tn | 5.5% | United States |
| Lower Limb Arterial Disease Management | USD 4.1 bn | USD 8.2 bn | 7.2% | United States |
| Lyophilization Equipment | USD 3.1 bn | USD 6.5 bn | 7.6% | United States |
| MRI-based Quantitative Biomarkers | USD 348 mn | USD 1.4 bn | 15.0% | United States |
| Mail Order Pharmacy | USD 172 bn | USD 338 bn | 7.0% | United States |
| Manufacturing on Demand for Medical | USD 1.2 bn | USD 3.2 bn | 10.0% | United States |
| Marine Toxin | USD 149 mn | USD 267 mn | 6.0% | United States |
| Mass Spectrometry | USD 6.6 bn | USD 13.1 bn | 7.0% | United States |
| Mechanical Thrombectomy System | USD 1.7 bn | USD 4.3 bn | 10.0% | United States |
| Medical Billing | USD 20.0 bn | USD 56.7 bn | 11.0% | United States |
| Medical Cannula | USD 2.3 bn | USD 3.9 bn | 5.3% | United States |
| Medical Device Cyber Risk Quantification | USD 244 mn | USD 986 mn | 15.0% | United States |
| Medical Devices | USD 675 bn | USD 1.2 tn | 5.5% | United States |
| Medical Imaging | USD 50.6 bn | USD 82.5 bn | 5.0% | United States |
| Medical Pendant | USD 1.3 bn | USD 2.3 bn | 6.0% | United States |
| Medical Telepresence Robots | USD 119 mn | USD 256 mn | 8.0% | United States |
| Medical Tourism | USD 40.3 bn | USD 125 bn | 12.0% | Turkey |
| Mental Health Services | USD 511 bn | USD 915 bn | 6.0% | United States |
| Metered Dose Inhaler | USD 17.9 bn | USD 29.1 bn | 5.0% | United States |
| Micro Balloon Catheter | USD 554 mn | USD 1.0 bn | 6.2% | United States |
| Microplate Reader | USD 1.7 bn | USD 3.1 bn | 6.5% | United States |
| Microsphere Drug Delivery | USD 6.0 bn | USD 13.0 bn | 8.0% | United States |
| Microwave Ablation Devices | USD 1.2 bn | USD 2.9 bn | 9.5% | China |
| Mixed Reality Navigation Platforms | USD 378 mn | USD 1.8 bn | 17.0% | United States |
| Molecular Diagnostics | USD 32.4 bn | USD 69.9 bn | 8.0% | United States |
| Monoclonal Antibodies | USD 273 bn | USD 512 bn | 6.5% | United States |
| Multi-Organ Transplant Monitoring | USD 1.1 bn | USD 2.5 bn | 9.0% | United States |
| Multiplex Sepsis Biomarker Panels | USD 203 mn | USD 632 mn | 12.0% | United States |
| Muscle Stimulation Devices | USD 1.4 bn | USD 2.5 bn | 5.8% | United States |
| NICU Modular Nutrition | USD 403 mn | USD 708 mn | 5.8% | United States |
| Nanomedicine | USD 20.1 bn | USD 47.5 bn | 9.0% | United States |
| Nasal Congestion Treatment Devices | USD 735 mn | USD 1.2 bn | 4.8% | United States |
| Nasal Drug Delivery | USD 19.1 bn | USD 34.8 bn | 6.2% | United States |
| Nasal Spray | USD 35.0 bn | USD 59.8 bn | 5.5% | United States |
| Nebulizer | USD 1.5 bn | USD 2.8 bn | 6.0% | United States |
| Neurofibromatosis Therapeutics | USD 889 mn | USD 2.5 bn | 11.0% | United States |
| Neuromodulation Closed-Loop Brain-Computer Interfaces | USD 598 mn | USD 2.2 bn | 14.0% | United States |
| Neurorehabilitation Technology | USD 3.4 bn | USD 8.0 bn | 9.0% | United States |
| Neurosurgery & Spine Robots | USD 1.4 bn | USD 4.5 bn | 12.0% | United States |
| New Approach Methodologies Nonclinical Testing | USD 2.2 bn | USD 7.4 bn | 13.0% | United States |
| Next Generation Sequencing | USD 16.4 bn | USD 55.6 bn | 13.0% | United States |
| Nuclear Medicine | USD 4.0 bn | USD 7.4 bn | 6.2% | United States |
| Nutraceutical | USD 516 bn | USD 1.1 tn | 7.5% | United States |
| Obesity Drugs | USD 33.3 bn | USD 123 bn | 14.0% | United States |
| Ocular Drug Delivery | USD 29.7 bn | USD 53.2 bn | 6.0% | United States |
| Oligonucleotide Therapeutics | USD 12.2 bn | USD 53.8 bn | 16.0% | United States |
| Omega-3 Supplements | USD 5.5 bn | USD 9.9 bn | 6.0% | United States |
| Oncology Biomarker Translation Services | USD 990 mn | USD 2.5 bn | 9.5% | United States |
| Oncology Drugs | USD 294 bn | USD 697 bn | 9.0% | United States |
| Oncolytic Virus Cancer Therapy | USD 342 mn | USD 2.1 bn | 20.0% | United States |
| Ophthalmic Gas Delivery | USD 74 mn | USD 117 mn | 4.8% | United States |
| Ophthalmic Stereoscopic 3D Display | USD 314 mn | USD 890 mn | 11.0% | United States |
| Oral Drug Delivery | USD 22.6 bn | USD 46.5 bn | 7.5% | United States |
| Organ Preservation & Perfusion Products | USD 1.4 bn | USD 4.0 bn | 11.0% | United States |
| Organ Preservation Solution | USD 454 mn | USD 935 mn | 7.5% | United States |
| Orthopedic Devices | USD 65.1 bn | USD 106 bn | 5.0% | United States |
| Orthopedic Prosthetic Accessories | USD 686 mn | USD 1.1 bn | 5.3% | United States |
| Osteotomy Plates | USD 506 mn | USD 849 mn | 5.3% | United States |
| Ostomy Irrigation Products | USD 94 mn | USD 143 mn | 4.3% | United States |
| Otoacoustic Emissions Hearing Screener | USD 136 mn | USD 218 mn | 4.8% | United States |
| Over the Counter Drugs | USD 184 bn | USD 299 bn | 5.0% | United States |
| PET Imaging Workflow | USD 456 mn | USD 984 mn | 8.0% | United States |
| Patient Recruitment | USD 5.2 bn | USD 12.4 bn | 9.0% | United States |
| Patient-Matched Orthopedic Guides | USD 642 mn | USD 1.2 bn | 6.8% | United States |
| Patient-Specific Surgical Implant Design | USD 722 mn | USD 2.0 bn | 10.5% | United States |
| Pen Injector | USD 6.7 bn | USD 17.3 bn | 10.0% | United States |
| Peptide Receptor Radionuclide Therapy (PRRT) | USD 913 mn | USD 2.0 bn | 8.0% | United States |
| Peptide Therapeutics | USD 110 bn | USD 342 bn | 12.0% | United States |
| Perimenopause Nutrition Products | USD 852 mn | USD 1.5 bn | 6.0% | United States |
| Pharma Peeler Centrifuge | USD 191 mn | USD 335 mn | 5.8% | India |
| Pharmaceutical Closure | USD 7.9 bn | USD 13.7 bn | 5.6% | United States |
| Pharmaceutical Cold Chain | USD 21.6 bn | USD 46.6 bn | 8.0% | United States |
| Pharmaceutical Distribution | USD 1.6 tn | USD 2.7 tn | 5.5% | United States |
| Pharmaceutical Excipients | USD 10.1 bn | USD 19.0 bn | 6.5% | United States |
| Pharmaceutical Filtration | USD 15.8 bn | USD 37.4 bn | 9.0% | United States |
| Pharmaceutical Glass | USD 19.4 bn | USD 38.8 bn | 7.2% | United States |
| Pharmaceutical Labeling | USD 9.0 bn | USD 15.8 bn | 5.8% | United States |
| Pharmaceutical Omega-3 API | USD 546 mn | USD 933 mn | 5.5% | United States |
| Pharmaceutical Serialization | USD 3.7 bn | USD 8.8 bn | 9.0% | United States |
| Pharmaceuticals | USD 1.8 tn | USD 3.2 tn | 6.0% | United States |
| Pharmacy | USD 2.0 tn | USD 3.2 tn | 5.0% | United States |
| Point of Care Testing | USD 44.9 bn | USD 88.4 bn | 7.0% | United States |
| Point-of-Care Respiratory Diagnostic Panels | USD 2.2 bn | USD 4.2 bn | 6.5% | United States |
| Polymerase Chain Reaction | USD 11.6 bn | USD 21.7 bn | 6.5% | United States |
| Precision Medicine | USD 42.2 bn | USD 120 bn | 11.0% | United States |
| Precision Transplant Medicine | USD 770 mn | USD 1.9 bn | 9.5% | United States |
| Prefilled Syringe | USD 8.5 bn | USD 19.1 bn | 8.5% | United States |
| Protein Purification | USD 9.3 bn | USD 21.9 bn | 9.0% | United States |
| Protein-Free Nutrition Module | USD 160 mn | USD 301 mn | 6.5% | United States |
| Proton Therapy | USD 1.4 bn | USD 2.9 bn | 8.0% | United States |
| RNA Therapeutics | USD 13.4 bn | USD 70.2 bn | 18.0% | United States |
| Radiopharmaceuticals | USD 12.1 bn | USD 39.3 bn | 12.5% | United States |
| Radiotherapy | USD 7.2 bn | USD 14.0 bn | 6.8% | United States |
| Radiotherapy Positioning Devices | USD 933 mn | USD 1.6 bn | 5.8% | United States |
| Rare Cardiovascular Disease Therapeutics | USD 16.1 bn | USD 38.1 bn | 9.0% | United States |
| Regenerative Medicine | USD 31.6 bn | USD 107 bn | 13.0% | United States |
| Remote Patient Monitoring | USD 25.7 bn | USD 114 bn | 16.0% | United States |
| Reproductive Toxicity Studies | USD 549 mn | USD 919 mn | 5.3% | United States |
| Respiration Monitor Belt | USD 63 mn | USD 105 mn | 5.2% | United States |
| Respiratory Trainer | USD 506 mn | USD 849 mn | 5.3% | United States |
| Retail Clinic | USD 6.3 bn | USD 10.6 bn | 5.3% | United States |
| Revenue Cycle Management | USD 68.8 bn | USD 195 bn | 11.0% | United States |
| Robotic Catheterization Systems | USD 944 mn | USD 3.8 bn | 15.0% | United States |
| Robotic Rehab Tools | USD 1.2 bn | USD 3.9 bn | 12.0% | United States |
| Rubber Stopper | USD 1.6 bn | USD 2.9 bn | 6.3% | United States |
| Safety Syringe | USD 4.5 bn | USD 9.8 bn | 8.0% | United States |
| Shelf-Stable Clinical Meal | USD 551 mn | USD 1.0 bn | 6.5% | United States |
| Single Use Bioreactor | USD 6.2 bn | USD 19.1 bn | 12.0% | United States |
| Small Molecule Drugs | USD 1.0 tn | USD 1.6 tn | 5.0% | United States |
| Smart Breast Imaging | USD 366 mn | USD 2.1 bn | 19.0% | United States |
| Smart Inhaler | USD 713 mn | USD 2.9 bn | 15.0% | United States |
| Softgel Capsule | USD 9.6 bn | USD 18.2 bn | 6.6% | United States |
| Specialty Pharmacy | USD 523 bn | USD 1.2 tn | 8.5% | United States |
| Spectroscopy | USD 15.4 bn | USD 27.5 bn | 6.0% | United States |
| Spray Drying | USD 3.0 bn | USD 5.1 bn | 5.3% | China |
| Sterile Injectable | USD 454 bn | USD 1.0 tn | 8.5% | United States |
| Sterile Single-Use Endoscopy Accessories | USD 5.4 bn | USD 11.1 bn | 7.5% | United States |
| Sterilization Equipment | USD 11.7 bn | USD 20.9 bn | 6.0% | United States |
| Surgical Robotics | USD 17.7 bn | USD 65.5 bn | 14.0% | United States |
| Swine Disease Diagnostic Kit | USD 405 mn | USD 739 mn | 6.2% | China |
| Synthetic Clinical Trial Data | USD 260 mn | USD 1.9 bn | 22.0% | United States |
| Syringe | USD 21.2 bn | USD 39.8 bn | 6.5% | United States |
| Tablet | USD 580 bn | USD 991 bn | 5.5% | United States |
| Tablet Press | USD 1.2 bn | USD 2.0 bn | 5.5% | India |
| Tangential Flow Filtration | USD 2.5 bn | USD 5.9 bn | 9.0% | United States |
| Tattoo Removal Laser | USD 454 mn | USD 935 mn | 7.5% | United States |
| Telemedicine | USD 103 bn | USD 348 bn | 13.0% | United States |
| Theranostic Workflow Platforms | USD 156 mn | USD 816 mn | 18.0% | United States |
| Tissue Engineering | USD 6.0 bn | USD 16.4 bn | 10.5% | United States |
| Touch Activated Phlebotomy Devices | USD 72 mn | USD 377 mn | 18.0% | United States |
| Track and Trace | USD 5.7 bn | USD 14.0 bn | 9.5% | United States |
| Transdermal Drug Delivery | USD 7.6 bn | USD 13.7 bn | 6.0% | United States |
| Transplant Biomarker Risk Stratification | USD 616 mn | USD 1.4 bn | 8.5% | United States |
| UV-C Disinfection Robots | USD 382 mn | USD 751 mn | 7.0% | United States |
| Ultrafiltration | USD 6.4 bn | USD 15.7 bn | 9.5% | China |
| Urethral Balloon Catheters | USD 1.4 bn | USD 2.1 bn | 4.3% | United States |
| Urgent Care | USD 49.8 bn | USD 91.8 bn | 6.3% | United States |
| Urology Ablation Devices | USD 1.1 bn | USD 2.8 bn | 10.0% | United States |
| Vaccine Cryoprotectants | USD 81 mn | USD 176 mn | 8.0% | United States |
| Vaccines | USD 80.6 bn | USD 158 bn | 7.0% | United States |
| Vaginitis Screening Assays | USD 821 mn | USD 1.7 bn | 7.5% | United States |
| Vaporized Hydrogen Peroxide Sterilization System | USD 905 mn | USD 1.8 bn | 7.0% | United States |
| Vascular Thromboembolic Disease Thrombectomy | USD 1.5 bn | USD 5.1 bn | 13.0% | United States |
| Veterinary Allergy Diagnostics | USD 321 mn | USD 603 mn | 6.5% | United States |
| Veterinary Dental Equipment | USD 371 mn | USD 652 mn | 5.8% | United States |
| Veterinary Health | USD 187 bn | USD 368 bn | 7.0% | United States |
| Vial | USD 9.7 bn | USD 19.9 bn | 7.5% | United States |
| Vibriosis Treatment Products | USD 191 mn | USD 335 mn | 5.8% | China |
| Virus Inactivation | USD 935 mn | USD 2.4 bn | 10.0% | United States |
| Waterless Bathing Solution | USD 475 mn | USD 796 mn | 5.3% | United States |
| Wearable Defibrillator Patch | USD 490 mn | USD 1.1 bn | 8.5% | United States |
| Wearable Injector | USD 1.1 bn | USD 3.9 bn | 13.0% | United States |
| Widefield Imaging Systems | USD 551 mn | USD 1.0 bn | 6.5% | United States |
| Wound Care | USD 26.5 bn | USD 47.5 bn | 6.0% | United States |
| Wound Care Surfactant | USD 405 mn | USD 739 mn | 6.2% | United States |
| Wound Irrigation Systems | USD 551 mn | USD 969 mn | 5.8% | United States |